Searchable abstracts of presentations at key conferences in endocrinology

ea0093oc54 | Oral communication 9: Calcium and Bone | EYES2023

Bone metabolism in mice requires canonical TRA action

Schoerding Ann-Kathrin , Geist Daniela , Hones G Sebastian , Moller Lars Christian , Williams Graham Richard , Bassett John Howard Duncan

Background: Thyroid hormone (TH) action is mediated by TH receptors (TRs) α&β. Both regulate gene expression by binding TREs on the DNA (canonical signaling) or activate cellular signaling pathways (noncanonical signaling). Bone is a major TH target and noncanonical TR α & β effects on bone metabolism were suggested. We studied mouse model bones to distinguish between signaling types.Methods: Growth of WT mice and mice with ei...

ea0095oc1.2 | Oral Communications 1 | BSPED2023

45,X/46,XY DSD with gender dysphoria: the conundrum around pubertal induction

Chatterjee Sumana , Alderson Julie , Edwards Zoe , Mcandrew Fiona , Williams Cara , Das Urmi , Awad Karim , Park Julie , Giri Dinesh

Introduction: Mixed gonadal dysgenesis (MGD) is a rare form of difference in sex development (DSD) characterised by mosaic karyotype of 45,X/46,XY and dysgenetic gonads. Gender dysphoria can be associated, the frequency of which is unknown. We describe 2 cases of MGD with gender dysphoria and the conundrum around pubertal induction.Case 1: An 8-year-old, reared as a girl, presented with longstanding concerns about appear...

ea0098o6 | Other | NANETS2023

PRESTO 3: An international, simulated-use study assessing preferences of nurses between two lanreotide syringes (Somatuline® Autogel® vs Pharmathen)

Ferone Diego , Martin Wendy , Williams Jessica , Houchard Aude , Pommie Christelle , Mai Truong-Thanh Xuan , Ribeiro-Oliveira Jr. Antonio , Grossman Ashley

Background: Patients with neuroendocrine tumours (NETs) and acromegaly are commonly treated with somatostatin analogs (SSAs), such as octreotide and lanreotide depot formulations. The Pharmathen syringe is now available in several European countries and the USA for lanreotide depot injection. When using SSAs, confidence in and ease of use with syringes are important for decision-making in long-term therapy. The aim of the PRESTO 3 study was to compare nurses’ preference f...

ea0081oc13.1 | Oral Communications 13: Adrenal and Cardiovascular Endocrinology 2 | ECE2022

Development of [18F]AldoView as the first highly selective aldosterone synthase PET tracer for imaging of patients with primary hyperaldosteronism

Sander Kerstin , Kurzawinski Tom , Gendron Thibault , Cybulska Klaudia , Sirindil Fatih , Zhou Junhua , Kalber Tammy , Lythgoe Mark , Brown Morris , Williams Bryan , Arstad Erik

Background: Inappropriately high aldosterone in patients with primary hyperaldosteronism (PHA) is due to increased aldosterone synthase (CYP11B2) activity. Selective in vivo imaging of overexpressed CYP11B2 in adrenals with positron emission tomography (PET) has not yet been achieved due to close homology of enzymes involved in aldosterone and cortisol (CYP11B1) synthesis.Aim: Synthesize a fluorine-18 labelled highly selective CYP11B2 inhibitor, [18...

ea0081p79 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Non-invasive quantification of pancreatic islet beta-cell function in people with type 1 diabetes mellitus

Joshi Shruti , Singh Trisha , Kershaw Lucy , Gibb Fraser , Dweck Marc R , Williams Michelle , Semple Scott , Forbes Shareen , Reynolds Rebecca , Newby David

Background and Aims: Type 1 diabetes mellitus (T1DM) is characterised by autoimmune destruction of pancreatic beta-cells resulting in insulin deficiency. Evaluation of novel therapies for T1DM requires reliable methods to measure beta-cell function, which is unattainable using traditional non-invasive imaging techniques. A new approach is manganese-enhanced magnetic resonance imaging (MEMRI). As a calcium analogue, manganese is taken up into pancreatic beta-cells during insuli...

ea0086oc1.2 | Bone and Calcium | SFEBES2022

Hypercalcaemic mice harbouring a germline ablation of G-protein subunit alpha-11 have anaemia that is corrected by treatment with erythropoietin

Hannan Fadil , Stevenson Mark , Kooblall Kreepa , Olesen Mie , Yon Marianne , Stewart Michelle , Wells Sara , Duncan Bassett J.H. , Williams Graham , Thakker Rajesh

G-protein subunit α-11 (Gα11), which is encoded by GNA11, plays a major role in calcium homeostasis by regulating parathyroid hormone (PTH) secretion, and germline loss-of-function mutations cause familial hypocalciuric hypercalcaemia type 2 (FHH2). Since Gα11 is ubiquitously expressed, we investigated whether FHH2 is associated with additional non-calcitropic phenotypes by analysing mice harbouring a homozygous germline deletion o...

ea0066oc4.7 | Oral Communications 4 | BSPED2019

Novel variants in the Leucine-zipper-like transcription regulator 1 (LZTR1) gene cause Noonan syndrome phenotype by upregulation of the RAS-MAPKinase pathway

Chatterjee Sumana , Bertola Debora , Agwu Chizo , Karantza Maria , Cottrell Emily , Shapiro Lucy , Maharaj Avinaash V , Williams Jack , Savage Martin O , Gaston-Massuet Carles , Metherell Louise A , Storr Helen L

Objectives: Noonan Syndrome (NS) is an autosomal dominant multi-system disorder characterised by short stature (SS), distinctive facial features and cardiovascular abnormalities. Mutations in multiple genes regulating the RAS-MAPK pathway have been identified in NS including 5 recently described novel LZTR1 variants. We identified 2 novel LZTR1 variants in patients with features of growth hormone insensitivity and NS. The molecular function of LZTR1 ...

ea0063p37 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas

Yang Yuhong , Meyer Lucie S , Jaquin Diana , Schneider Holger , Ploncynski Maria , Beuschlein Felix , Gomez-Sanchez Celso E , Reincke Martin , Williams Tracy Ann

Background: Primary aldosteronism is commonly caused by an aldosterone-producing adenoma (APA). Somatic mutations in the KCNJ5 gene (encoding an inwardly rectifying potassium channel) are found in around 40% of APAs, KCNJ5 germline mutations cause familial hyperaldosteronism type III. The role of KCNJ5 mutations in excessive aldosterone production is established but their role in cell growth is unclear.Objective: To study the e...

ea0044oc3.3 | Thyroid and Neoplasia | SFEBES2016

Post-Radioiodine Graves’ Management: The Pragma-Study

Perros Petros , Dayan Colin , Vaidya Bijay , Williams Graham , Lazarus John H , Hickey Janis , Willis Debbie , Archer Natasha , Franklyn Jayne , Basu Ansu

Introduction: Radioiodine (RI) is a safe and effective treatment for Graves’ disease. In the months following RI different strategies are used to gain control of thyroid status, although there is no evidence base as to the optimal approach.Objectives: To compare the incidence of dysthyroidism post-RI between three principal management strategies employed by clinicians.Study design and methods: Retrospective, observational, mul...

ea0058oc6.1 | Oral Communications 6 | BSPED2018

A retrospective regional analysis of outcomes during transition of young people with type 1 diabetes

Kershaw Melanie , Atkins Marie , Digwood Suzanne , McCoubrey Hilary , McGee Marie , Pargass Nisha , Raghavan Rajeev , Rookes Raphaella , Rweyemamu Justina , Sankar Sailesh , Skelding Rebecca , Swift Lesley , Williams Kerrie

Objectives: Transition from paediatric (PC) to adult diabetes care (AC) is a vulnerable period for young people (YP). The West Midlands (WM) Regional Paediatric Diabetes Network conducted a region-wide study of Diabetes transition outcomes to identify 1. Areas of good practice, 2. Risk factors for poorer outcomes, 3. Regional objectives for services and 4. Provide baseline data against which future performance can be measured.Methods: Retrospective regio...